![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: TRIP10 |
Gene summary for TRIP10 |
![]() |
Gene information | Species | Human | Gene symbol | TRIP10 | Gene ID | 9322 |
Gene name | thyroid hormone receptor interactor 10 | |
Gene Alias | CIP4 | |
Cytomap | 19p13.3 | |
Gene Type | protein-coding | GO ID | GO:0006810 | UniProtAcc | Q15642 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
9322 | TRIP10 | LZE4T | Human | Esophagus | ESCC | 3.46e-06 | -7.02e-02 | 0.0811 |
9322 | TRIP10 | LZE8T | Human | Esophagus | ESCC | 3.55e-03 | 4.39e-02 | 0.067 |
9322 | TRIP10 | LZE22D1 | Human | Esophagus | HGIN | 1.26e-05 | 1.31e-01 | 0.0595 |
9322 | TRIP10 | LZE24T | Human | Esophagus | ESCC | 3.48e-04 | 3.61e-01 | 0.0596 |
9322 | TRIP10 | LZE21T | Human | Esophagus | ESCC | 8.70e-07 | 8.11e-02 | 0.0655 |
9322 | TRIP10 | P1T-E | Human | Esophagus | ESCC | 2.85e-05 | 9.60e-01 | 0.0875 |
9322 | TRIP10 | P2T-E | Human | Esophagus | ESCC | 4.04e-14 | -6.35e-02 | 0.1177 |
9322 | TRIP10 | P4T-E | Human | Esophagus | ESCC | 1.61e-15 | 1.64e-02 | 0.1323 |
9322 | TRIP10 | P5T-E | Human | Esophagus | ESCC | 3.14e-18 | 2.77e-01 | 0.1327 |
9322 | TRIP10 | P8T-E | Human | Esophagus | ESCC | 1.85e-48 | 1.12e+00 | 0.0889 |
9322 | TRIP10 | P9T-E | Human | Esophagus | ESCC | 1.77e-07 | 5.76e-02 | 0.1131 |
9322 | TRIP10 | P10T-E | Human | Esophagus | ESCC | 7.58e-08 | 1.21e-01 | 0.116 |
9322 | TRIP10 | P11T-E | Human | Esophagus | ESCC | 2.45e-02 | 9.98e-02 | 0.1426 |
9322 | TRIP10 | P12T-E | Human | Esophagus | ESCC | 4.05e-17 | 1.21e-01 | 0.1122 |
9322 | TRIP10 | P15T-E | Human | Esophagus | ESCC | 2.16e-09 | 1.47e-01 | 0.1149 |
9322 | TRIP10 | P16T-E | Human | Esophagus | ESCC | 2.36e-14 | -1.02e-01 | 0.1153 |
9322 | TRIP10 | P17T-E | Human | Esophagus | ESCC | 2.46e-10 | 1.66e-01 | 0.1278 |
9322 | TRIP10 | P20T-E | Human | Esophagus | ESCC | 4.31e-11 | 2.22e-02 | 0.1124 |
9322 | TRIP10 | P21T-E | Human | Esophagus | ESCC | 4.53e-13 | 1.91e-01 | 0.1617 |
9322 | TRIP10 | P22T-E | Human | Esophagus | ESCC | 1.66e-08 | -1.82e-01 | 0.1236 |
Page: 1 2 3 4 5 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa049109 | Esophagus | ESCC | Insulin signaling pathway | 89/4205 | 137/8465 | 1.97e-04 | 7.32e-04 | 3.75e-04 | 89 |
hsa0491014 | Esophagus | ESCC | Insulin signaling pathway | 89/4205 | 137/8465 | 1.97e-04 | 7.32e-04 | 3.75e-04 | 89 |
hsa049108 | Oral cavity | OSCC | Insulin signaling pathway | 83/3704 | 137/8465 | 4.83e-05 | 2.00e-04 | 1.02e-04 | 83 |
hsa0491013 | Oral cavity | OSCC | Insulin signaling pathway | 83/3704 | 137/8465 | 4.83e-05 | 2.00e-04 | 1.02e-04 | 83 |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
TRIP10 | SNV | Missense_Mutation | novel | c.263A>G | p.Glu88Gly | p.E88G | Q15642 | protein_coding | deleterious(0) | benign(0.015) | TCGA-B5-A3FC-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
TRIP10 | SNV | Missense_Mutation | novel | c.1657G>A | p.Gly553Arg | p.G553R | Q15642 | protein_coding | deleterious(0) | probably_damaging(0.999) | TCGA-B5-A3FC-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
TRIP10 | SNV | Missense_Mutation | rs201134453 | c.1229G>A | p.Arg410His | p.R410H | Q15642 | protein_coding | deleterious(0) | probably_damaging(0.984) | TCGA-BS-A0UV-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD |
TRIP10 | SNV | Missense_Mutation | c.1557A>C | p.Glu519Asp | p.E519D | Q15642 | protein_coding | tolerated(0.25) | benign(0.003) | TCGA-BS-A0UV-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD | |
TRIP10 | SNV | Missense_Mutation | c.571N>A | p.Ala191Thr | p.A191T | Q15642 | protein_coding | deleterious(0) | probably_damaging(0.936) | TCGA-D1-A103-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
TRIP10 | SNV | Missense_Mutation | novel | c.173C>A | p.Pro58His | p.P58H | Q15642 | protein_coding | deleterious(0.02) | possibly_damaging(0.776) | TCGA-DF-A2KN-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | Unknown | I/II | Unknown | Unknown | SD |
TRIP10 | SNV | Missense_Mutation | rs768215231 | c.814N>T | p.His272Tyr | p.H272Y | Q15642 | protein_coding | tolerated(1) | possibly_damaging(0.827) | TCGA-DI-A1BU-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Chemotherapy | paclitaxel | SD |
TRIP10 | SNV | Missense_Mutation | novel | c.214N>C | p.Ser72Pro | p.S72P | Q15642 | protein_coding | deleterious(0) | possibly_damaging(0.764) | TCGA-E6-A1M0-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | carboplatin | SD |
TRIP10 | SNV | Missense_Mutation | novel | c.67G>A | p.Asp23Asn | p.D23N | Q15642 | protein_coding | deleterious(0) | probably_damaging(0.987) | TCGA-EO-A22U-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
TRIP10 | SNV | Missense_Mutation | novel | c.153N>C | p.Lys51Asn | p.K51N | Q15642 | protein_coding | deleterious(0) | probably_damaging(0.993) | TCGA-EY-A1GI-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 4 5 6 7 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |